VAERS Explorer
Back to explore

Report #2827194

Received Mar 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
5 yrs
State
ND
Recovered
Unknown
Vaccinated
Dec 18, 2024
Onset
Dec 18, 2024
Days to onset
0
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
FLUC4INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)SEQIRUS, INC.2946595IM / LL
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.2Y013579SC / LL
UNKVACCINE NOT SPECIFIED (NO BRAND NAME)UNKNOWN MANUFACTURER2Y013579OT / LL

Symptoms (2)

Product storage errorNo adverse event

Symptom narrative

No adverse event; Improper storage of product in use; This spontaneous report was received from a registered nurse and refers to a 5-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Flucelvax quadrivalent (Influenza vaccine inact sAg 4v). On 01-OCT-2024, the facility received a shipment of COVID vaccine that needed to be stored in the freezer. There was no room in the freezer to accommodate the shipment. It was assumed that the Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) received could be stored in both the freezer and refrigerator and both state and private Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) were moved to the refrigerators where they remained within normal refrigerated temperature range until administration. The dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) administered to the client arrived at facility on 13-NOV-2024 and was stored in the refrigerator until administered on 18-DEC-2024. On 18-DEC-2024, the patient was vaccinated with the second dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y013579, expiration date: 03-Feb-2026), administered by Subcutaneous route in Left Thigh (exact dose was not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot number and expiry dates were not provided) (improper storage of product in use). No additional adverse event reported (no adverse event). This case was one of several reports received from the same reporter with the case US-009507513-2254349.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : @merck.com , Index date : 2025-02-26 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : 12/XX/2018 , Central date : 2025-02-20 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :

Other medications

Influenza (Seasonal) (flucelvax quadrivalent); Sterile Diluent Solution for Injection